Re­gen­er­a­tive cell biotech Thym­mune launch­es with back­ing from George Church, John Maraganore

Thym­mune Ther­a­peu­tics is go­ing af­ter “the most im­por­tant or­gan you’ve nev­er heard of,” ac­cord­ing to Pil­lar VC’s Thomas de Vlaam.

The Cam­bridge, MA-based biotech has …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER